On May 23, 2023, Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) opened at $17.01, lower -3.10% from the last session. During the day, the shares moved up to $17.97 and dropped to $16.515 before settling in for the closing price of $17.07. Price fluctuations for RYTM have ranged from $3.06 to $34.99 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -147.60% at the time writing. With a float of $56.17 million, this company’s outstanding shares have now reached $56.71 million.
Let’s determine the extent of company efficiency that accounts for 177 employees. In terms of profitability, gross margin is +87.19, operating margin of -757.92, and the pretax margin is -766.22.
Rhythm Pharmaceuticals Inc. (RYTM) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rhythm Pharmaceuticals Inc. is 0.10%, while institutional ownership is 108.52%. The most recent insider transaction that took place on Mar 29, was worth 15,960. In this transaction Chief Accounting Officer of this company sold 912 shares at a rate of $17.50, taking the stock ownership to the 7,872 shares. Before that another transaction happened on Feb 14, when Company’s EVP, Head of International sold 1,177 for $27.03, making the entire transaction worth $31,814. This insider now owns 3,827 shares in total.
Rhythm Pharmaceuticals Inc. (RYTM) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/30/2023, the company posted -$0.92 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.73) by -$0.19. This company achieved a net margin of -766.22 while generating a return on equity of -66.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -147.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.00% during the next five years compared to -4.20% drop over the previous five years of trading.
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) Trading Performance Indicators
Check out the current performance indicators for Rhythm Pharmaceuticals Inc. (RYTM). In the past quarter, the stock posted a quick ratio of 6.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.36, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -2.55 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc. (RYTM)
Looking closely at Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM), its last 5-days average volume was 0.67 million, which is a jump from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 29.10%. Additionally, its Average True Range was 1.00.
During the past 100 days, Rhythm Pharmaceuticals Inc.’s (RYTM) raw stochastic average was set at 3.10%, which indicates a significant decrease from 8.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.22% in the past 14 days, which was lower than the 59.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.20, while its 200-day Moving Average is $23.81. However, in the short run, Rhythm Pharmaceuticals Inc.’s stock first resistance to watch stands at $17.50. Second resistance stands at $18.46. The third major resistance level sits at $18.96. If the price goes on to break the first support level at $16.05, it is likely to go to the next support level at $15.55. Now, if the price goes above the second support level, the third support stands at $14.59.
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) Key Stats
There are currently 56,855K shares outstanding in the company with a market cap of 925.25 million. Presently, the company’s annual sales total 23,640 K according to its annual income of -181,120 K. Last quarter, the company’s sales amounted to 11,470 K and its income totaled -52,180 K.
